cancer
Tislelizumab Plus Bevacizumab/Chemo Demonstrates Early Efficacy in Cervical Cancer
Posted in Medicine on 20th Jul, 2023
by Alex Muller
The addition of the PD-L1 inhibitor tislelizumab to standard bevacizumab and platinum-doublet chemotherapy in the first-line setting prolonged progression-free survival, produced encouraging responses, and was well tolerated in patients with cervical cancer.
Women treated for breast cancer may age faster than cancer-free women
Posted in Medicine on 20th Jul, 2023
by Alex Muller
NIH study finds radiation shows strongest association, less for surgery and endocrine treatments.
Predicting bone metastases type in prostate cancer using MRI
Posted in Medicine on 20th Jul, 2023
by Alex Muller
The findings suggest that MRI-based nT2SI measurement may be a valuable tool in predicting the type of BMs in prostate cancer, specifically distinguishing between osteoblastic and non-osteoblastic metastases.
Lung cancer diagnoses of UK women to outnumber men’s for first time
Posted in Medicine on 10th Jul, 2023
by Alex Muller
Lung cancer is the most common cause of cancer death in the UK, accounting for one in five of the total. It has one of the worst cancer survival rates, which is largely attributed to diagnoses at a late stage, when treatment is less likely to be effective.
Two Drugs May Be Better Than One for Resistant Breast Cancers
Posted in Medicine on 18th Jun, 2023
by Alex Muller
Overall, the study suggests that combining new CDK2 inhibitors with CDK4/6 inhibitors – such as palbociclib, ribociclib and abemaciclib – could be effective for patients with either intrinsic or acquired resistance.